HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates
Authors:
- 1 August 2021
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 87 (1) , S73-S80
Abstract
Background: HIV-1 incidence calculation currently includes recency classification by HIV-1 incidence assay and unsuppressed viral load (VL ≥ 1000 copies/mL) in a recent infection testing algorithm (RITA). However, persons with recent classification not virally suppressed and taking antiretroviral (ARV) medication may be misclassified. Setting: We used data from 13 African household surveys to describe the impact of an ARV-adjusted RITA on HIV-1 incidence estimates. Methods: HIV-seropositive samples were tested for recency using the HIV-1 Limiting Antigen (LAg)-Avidity enzyme immunoassay, HIV-1 viral load, ARVs used in each country, and ARV drug resistance. LAg-recent result was defined as normalized optical density values ≤1.5. We compared HIV-1 incidence estimates using 2 RITA: RITA1: LAg-recent + VL ≥ 1000 copies/mL and RITA2: RITA1 + undetectable ARV. We explored RITA2 with self-reported ARV use and with clinical history. Results: Overall, 357 adult HIV-positive participants were classified as having recent infection with RITA1. RITA2 reclassified 55 (15.4%) persons with detectable ARV as having long-term infection. Those with detectable ARV were significantly more likely to be aware of their HIV-positive status (84% vs. 10%) and had higher levels of drug resistance (74% vs. 26%) than those without detectable ARV. RITA2 incidence was lower than RITA1 incidence (range, 0%–30% decrease), resulting in decreased estimated new infections from 390,000 to 341,000 across the 13 countries. Incidence estimates were similar using detectable or self-reported ARV (R2 > 0.995). Conclusions: Including ARV in RITA2 improved the accuracy of HIV-1 incidence estimates by removing participants with likely long-term HIV infection.Keywords
This publication has 16 references indexed in Scilit:
- Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicatorsAIDS, 2017
- Simultaneous Detection of Major Drug Resistance Mutations of HIV-1 Subtype B Viruses from Dried Blood Spot Specimens by Multiplex Allele-Specific AssayJournal of Clinical Microbiology, 2016
- Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 SubtypesPLOS ONE, 2015
- Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repositoryAIDS, 2014
- A New General Biomarker-based Incidence EstimatorEpidemiology, 2012
- Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation StudiesPLOS ONE, 2012
- Errors in ‘BED’-Derived Estimates of HIV Incidence Will Vary by Place, Time and AgePLOS ONE, 2009
- A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent InfectionAIDS Research and Human Retroviruses, 2009
- Risk Factors for Recent HIV Infection in UgandaJAMA, 2008
- Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2005